Analysis of specific metabolite profiling of minimal hepatic encephalopathy based on metabolomics analytical platforms of GC-TOFMS and UPLC-QTOFMS

Huang GuoChu; Wang Meng; Yang XiaoHui; Yao Fan; Zhong Yu; Yao Chun

doi:10.3969/j.issn.1001-5256.2016.01.027

Volume 32 Issue 1

Jan. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(1): 139-142

PDF( 1594 KB)

Analysis of specific metabolite profiling of minimal hepatic encephalopathy based on metabolomics analytical platforms of GC-TOFMS and UPLC-QTOFMS

DOI: 10.3969/j.issn.1001-5256.2016.01.027

Department of Hepatology,First Affiliated Hospital,Guangxi University of Chinese Medicine

Research funding:

Received Date: 2015-05-28
Published Date: 2016-01-20

Abstract

Abstract

Objective To analyze and compare the serum metabolite profiling of healthy volunteers and patients with minimal hepatic encephalopathy( MHE),identify the specific biomarkers of MHE,and explore the method for early diagnosis of MHE. Methods Twenty-nine patients with MHE caused by hepatitis B cirrhosis who were admitted to First Affiliated Hospital of Guangxi University of Chinese Medicine( MHE group) from October 2013 to October 2014,as well as 50 healthy volunteers who received physical examinations in this hospital( NC group) during the same period,were collected. Gas chromatography and time- of- flight mass spectrometry( GC- TOFMS) and ultra- high- pressure liquid chromatography- quadrupole- time- of- flight mass spectrometry( UPLC- QTOFMS) were applied to determine the metabolites in serum samples. Principal component analysis( PCA) and orthogonal partial least squares- discriminant analysis( OPLS-DA) were applied for multivariate statistical analysis,and univariate t test was applied for comparison between the two groups,so as to determine the biomarkers for MHE. Results In combination of the modeling analysis with PCA and OPLS- DA,the results from univariate t test,and vasoactive intestinal peptide( VIP) value in the models,a total of 27 possible specific biomarkers for MHE were found in serum in the two groups. According to the fold change between MHE group and NC group in OPLS- DA model,there were 9 down- regulated metabolites and 18 up- regulated metabolites in the patients with MHE compared with healthy volunteers. Conclusion Serum metabolomics analytical platforms such as GC- TOFMS and UPLC- QTOFMS can detect a variety of metabolites in serum,which can be of help to explore the pathogenesis of MHE. In addition,the diagnostic model OPLS- DA established in this study can differentiate between the normal population and patients with MHE,which may be applied for early diagnosis of MHE.
- hepatic encephalopathy,
- mass spectrometry,
- early diagnosis

FullText(HTML)

References(17)

References

[1] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ.

[2]LIU CH,WEI BH,YAO SK.Clinic consensus of cirrhosis of integrative medicine[J].Chin J Integr Trad West Med Dig,2011,19(4):277-279.(in Chinese)刘成海,危北海,姚树坤.肝硬化中西医结合诊疗共识[J].中国中西医结合消化杂志,2011,19(4):277-279.

[3]Chinese Society of Gastroenterology and Chinese Society of Hepatology,Chinese Medical Association.Consensus on the diagnosis and treatment of hepatic encephalopathy in China(Chongqing,2013)[J/CD].Chin J Front Med Sci:Electronic Version,2014,6(2):81-93.(in Chinese)中华医学会消化病学分会,中华医学会肝病学分会.中国肝性脑病诊治共识意见(2013年,重庆)[J/CD].中国医学前沿杂志:电子版,2014,6(2):81-93.

[4]STENLUND H,GORZSS A,PERSSON P,et al.Orthogonal projections to latent structures discriminant analysis modeling on in situ FT-IR spectral imaging of liver tissue for identifying sources of variability.[J]Anal Chem,2008,80(18):6898-6906.

[5]WEISSENBORN K.Psychometric tests for diagnosing minimal hepatic encephalopathy[J].Metab Brain Dis,2013,28(2):227-229.

[6]ADROVER R,BARRIO M,ALBUQUERQUE M,et al.Validation of the number connection test for identifying patients with minimal hepatic encephalopathy[J].Acta Gastroenterol Latinoam,2012,42(2):105-111.

[7]QI JX.Research on minimal hepatic encephalopathy metabonomics[D].Dalian:Dalian Med Univ,2013.(in Chinese)齐俊霞.轻微肝性脑病代谢组学的研究[D].大连:大连医科大学,2013.

[8]ZHU J.Study of syndrome of damp-heat exuberant of HBV induced acute-on-chronic and subacute-on-chronic liver failure based on metabonomics[D].Wuhan:Hubei Tradit Chin Med Univ,2013.(in Chinese)朱洁.基于代谢组学的慢加急(亚急)性乙肝肝衰竭湿热证的证候研究[D].武汉:湖北中医药大学,2013.

[9]YANG LN,WEN J,SUN Y,et al.Metabonomic study on the anti-liver injury effect of Si-Ni-San on rats by using UPLC-MS/MS[J].Acta Pharm Sin,2014,49(3):368-373.(in Chinese)杨丽娜,温静,孙毅,等.四逆散抗肝损伤作用的大鼠血清UPLC-MS/MS代谢组学研究[J].药学学报,2014,49(3):368-373.

[10]GENG F,ZHANG N,FANG H,et al.Metabonomic study on protective effect of xiaoyao powder for acute hepatic injury in rats[J].J Chin Med Materls,2014,37(2):275-279.(in Chinese)耿放,张宁,方衡,等.逍遥散对急性肝损伤大鼠模型保护作用的代谢组学研究[J].中药材,2014,37(2):275-279.

[11]YANG T,LIU CH.Exploration on mechanism of different therapeutic effects of fuzheng huayu formula on different patients with liver fibrosis from the aspect of metabonomics[J].World Chin Med,2014,9(5):549-552,556.(in Chinese)杨涛,刘成海.基于代谢组学的扶正化瘀方抗肝纤维化差异疗效机制研究探讨[J].世界中医药,2014,9(5):549-552,556.

[12]HUANG Y.The serum metabolic profiling on different differentiation of HCC patients[D].Tianjin:Tianiin Med Univ,2014.(in Chinese)黄娅.不同分化程度肝细胞肝癌患者血清代谢轮廓分析[D].天津:天津医科大学,2014.

[13]LI XF.Metabolomics study of HBV-induced acute-on-chronic liver failure,chronic liver failure and pre-acute-on-chronic liver failure[D].Hangzhou:Zhejiang Univ,2014.(in Chinese)李小芬.乙肝慢加急性肝衰竭与慢性肝衰竭、肝衰竭前期血清代谢组学初步研究[D].杭州:浙江大学,2014.

[14]QI SW.Study on serum metabolic profiling in different stage of liver cirrhosis patients with hepatitis b virus infection[D].Chongqing:Chongqing Med Univ,2012.(in Chinese)齐素文.HBV肝硬化不同阶段血清代谢物组的研究[D].重庆:重庆医科大学,2012.

[15]XIE W,YAO C,YAO F,et al.Experimental study on minimal hepatic encephalopathy with LC-MS[J].Shanxi J Tradit Chin Med,2012,28(3):46-48.(in Chinese)谢武,姚春,姚凡,等.基于液相色谱-质谱(LC-MS)技术对轻微型肝性脑病的实验研究[J].山西中医,2012,28(3):46-48.

[16]KWONG E,LI Y,HYLEMON PB,et al.Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism[J].Acta Pharmaceutica Sinica B,2015,5(2):151-157.

[17]DISTRUTTI E,SANTUCCI L,CIPRIANI S,et al.Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa[J].J Gastroenterology,2015,50(7):1-13.

Relative Articles

[1]	Xuhong YANG, Yong YANG, Minglei WANG, Wenxiao LIU, Wanlong MA, Minxing WANG, Xiangchun DING, Xiaodong WANG. Value of blood ammonia and cholinesterase in the early diagnosis of liver cirrhosis with minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2023, 39(2): 339-344. doi: 10.3969/j.issn.1001-5256.2023.02.013
[2]	Yuhao YAO, Jiaxin ZHANG, Xiao XIA, Shun ZHU, Xiaoke LI, Yong'an YE. Effect of probiotics in preventing overt hepatic encephalopathy in patients with minimal hepatic encephalopathy: A Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2505-2509. doi: 10.3969/j.issn.1001-5256.2022.11.013
[3]	Teng WANG, Yijing ZHU, Shousong ZHAO. Value of Stroop test in the diagnosis of minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2022, 38(4): 828-831. doi: 10.3969/j.issn.1001-5256.2022.04.017
[4]	Xichen LIU, Yiying WANG, Manman TONG, Junjie QIN. Biomarkers for the early diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(1): 176-179. doi: 10.3969/j.issn.1001-5256.2021.01.038
[5]	ZHANG QinFu, HAN HuanQin, ZHENG WeiQiang. Serum biomarkers for the early diagnosis of minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2020, 36(12): 2819-2821. doi: 10.3969/j.issn.1001-5256.2020.12.037
[6]	Zhao YunSheng, Zhang LiNa, Huo LiJing, Pei Liu, Li QiuPing, Li HongChen, Jin Liang. Clinical value of fucosylated Golgi protein 73 in differential diagnosis of small hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(8): 1707-1711. doi: 10.3969/j.issn.1001-5256.2018.08.023
[7]	Luo XinChen, Zhou YouQian. Increasing early diagnosis of primary liver cancer by improving the compliance with regular screening in the high-risk population[J]. Journal of Clinical Hepatology, 2018, 34(8): 1788-1792. doi: 10.3969/j.issn.1001-5256.2018.08.044
[8]	Chen MinHua, Wu Wei. Value of contrast-enhanced ultrasound in early diagnosis of liver cancer and radiofrequency ablation treatment[J]. Journal of Clinical Hepatology, 2017, 33(7): 1211-1213. doi: 10.3969/j.issn.1001-5256.2017.07.002
[9]	Wang Ting, Liu Mei, Dong Lei, Duan ZhongPing. Application of tumor-associated antigens and their autoantibodies in early diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(7): 1418-1421. doi: 10.3969/j.issn.1001-5256.2016.07.047
[10]	Li Mi, Nie QingHe. Accuracy of Fibro Scan for diagnosis of primary liver cancer: a Meta-analysis[J]. Journal of Clinical Hepatology, 2016, 32(2): 312-316. doi: 10.3969/j.issn.1001-5256.2016.02.023
[11]	Zhu Chen, Sun YuanYuan, Jin Yan. Values of serum AFP, GGTⅡ and GP73 in diagnosis of primary hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(10): 1064-1066. doi: 10.3969/j.issn.1001-5256.2014.10.022
[12]	Gao HaiFeng. Value of combined detection of serum AFP and GP73 in early diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(7): 660-662. doi: 10.3969/j.issn.1001-5256.2014.07.022
[13]	Zhu MingYu, Chen Jie, Zhang XinXin. Research advances in serum biomarkers for early diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(10): 1091-1093. doi: 10.3969/j.issn.1001-5256.2014.10.029
[14]	Chen YangQin, Li Peng, Li Lei, Li Bing, Ding HuiGuo. Early diagnosis of nonalcoholic fatty liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1357-1360. doi: 10.3969/j.issn.1001-5256.2014.12.031
[15]	Li HaiPing, Gao Bo, Yu ZongTao, Liu JiuBo, Zhang JiCai. Significance of detection of multigene methylation in liver cancer tissue for early diagnosis of liver cancer[J]. Journal of Clinical Hepatology, 2013, 29(8): 624-626. doi: 10.3969/j.issn.1001-5256.2013.08.018
[16]	Ma QianYun, Zhu GeYuZheng. Diagnostic value of critical flicker frequency in minimal hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2012, 28(7): 559-561.
[17]	Zhang ChunHua. Application of mass spectrometry technique in the diagnosis of metabolic liver disease in children[J]. Journal of Clinical Hepatology, 2011, 27(7): 709-717+728.
[18]	Wang YuMing, Yan ZeHui. The new concepts on hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2010, 26(6): 568-574.
[19]	Wang Yu, Po YunFeng, Xu XianJi. A retrospective analysis of 74 patients with hipatic encephalopathy[J]. Journal of Clinical Hepatology, 2005, 21(3): 166-167.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	杜沅沁，王萌，黄国初，姚春，钟瑞熙，黄良江，徐健，黄晶晶，谭钦文，毛德文. 基于胆汁酸代谢组学探讨复方大黄煎剂保留灌肠对轻微型肝性脑病大鼠模型的治疗作用. 临床肝胆病杂志. 2023(10): 2348-2357 . 本站查看
2.	李开富，王萌，黄国初. 解毒化瘀方对轻微型肝性脑病患者血清代谢物谱的干预作用研究. 大众科技. 2019(10): 60-62+68 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2316) PDF downloads(449)

Analysis of specific metabolite profiling of minimal hepatic encephalopathy based on metabolomics analytical platforms of GC-TOFMS and UPLC-QTOFMS

DOI: 10.3969/j.issn.1001-5256.2016.01.027